Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease

被引：16
|
作者：
Marion, JF [1 ]
机构：
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA
来源：
INFLAMMATORY BOWEL DISEASES | 1998年 / 4卷 / 02期
关键词：
adverse reactions; azathioprine; Crohn's disease; drug use in pregnancy; 6-mercaptopurine; pediatric; ulcerative colitis;
D O I：
10.1097/00054725-199805000-00016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [21] Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
    Kotlyar, David S.
    Lewis, James D.
    Beaugerie, Laurent
    Tierney, Ann
    Brensinger, Colleen M.
    Gisbert, Javier P.
    Loftus, Edward V., Jr.
    Peyrin-Biroulet, Laurent
    Blonski, Wojciech C.
    Van Domselaar, Manuel
    Chaparro, Maria
    Sandilya, Sandipani
    Bewtra, Meenakshi
    Beigel, Florian
    Biancone, Livia
    Lichtenstein, Gary R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (05) : 847 - U541
  • [22] Expert opinion: Experience with 6-mercaptopurine in the treatment of inflammatory bowel disease
    Korelitz, Burton I.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (20) : 2979 - 2984
  • [23] 6-Mercaptopurine and inflammatory bowel disease
    Madrigal, EJD
    Garcia, LY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (06) : 455 - 456
  • [24] 6-Mercaptopurine and inflammatory bowel disease: Hidden ground for the cytomegalovirus
    Hookey, LC
    Depew, W
    Boag, A
    Vanner, S
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 17 (05) : 319 - 322
  • [25] EFFICACY OF 6-MERCAPTOPURINE IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    HINOJOSA, J
    MOLES, JR
    NOS, P
    HOYOS, M
    RAMIREZ, JJ
    PRIMO, J
    FERNANDEZ, J
    BERENGUER, JY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1995, 87 (11) : 775 - 780
  • [26] IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases
    Meuwissen, SGM
    Ewe, K
    Gassull, MA
    Geboes, K
    Jewell, D
    Pallone, F
    Rachmilewitz, D
    Rask-Madsen, J
    Riddell, BH
    Sandborn, BJ
    Schmuck, ML
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (01) : 13 - 18
  • [27] Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease
    Kader, HA
    Wenner, WJ
    Telega, GW
    Maller, ES
    Baldassano, RN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 30 (04) : 409 - 413
  • [28] Expert opinion: Experience with 6-mercaptopurine in the treatment of inflammatory bowel disease
    Burton I Korelitz
    World Journal of Gastroenterology, 2013, (20) : 2979 - 2984
  • [29] Summary of the workshop on 6-mercaptopurine/azathioprine pharmacology
    Markowitz, JF
    INFLAMMATORY BOWEL DISEASES, 1998, 4 (02) : 117 - 120
  • [30] Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease - Implications for therapy
    Derijks, LJJ
    Gilissen, LPL
    Engels, LGJB
    Bos, LP
    Bus, PJ
    Lohman, JJHM
    Curvers, WL
    van Deventer, SJH
    Hommes, DW
    Hooymans, PM
    THERAPEUTIC DRUG MONITORING, 2004, 26 (03) : 311 - 318
12345